Partner Headlines - SLXP

  1. Benzinga's M&A Chatter for Thursday December 18, 2014

    Benzinga
  2. Credit Suisse Raises Salix Pharmaceuticals Price Target

    Benzinga
  3. Salix rebounding from crash

    IBD
  4. Salix Destocking Plan, 2-Year Guidance Soothe Street

    IBD
  5. #PreMarket Movers From December 16, 2014

    Benzinga
  6. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus
  7. Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are ...

    Benzinga
  8. How Adam Feuerstein Follows The Biotech Sector

    Benzinga
  9. Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

    Benzinga
  10. U.S. Produced Fewer Than Expected Jobs In October

    Benzinga
  11. Health Sell-Offs Drag On IBD 50

    IBD
  12. Dow, S&P 500 Flirt With Record, But Finish Just Off

    IBD
  13. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  14. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  15. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  16. Mid-Day Market Update: Allscripts Healthcare Slides On Downbeat ...

    Benzinga
  17. Mid-Morning Market Update: Markets Edge Lower; Humana Profit ...

    Benzinga
  18. Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being ...

    Benzinga
  19. Morning Market Losers

    Benzinga
  20. Benzinga's Top Downgrades

    Benzinga
  21. Stocks Set For Higher Start After Mixed Jobs Report

    IBD
  22. Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold

    Benzinga
  23. Benzinga's Top #PreMarket Losers

    Benzinga
  24. UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered ...

    Benzinga
  25. Salix Dives On Earnings, Probe; Akorn A Bad Seed Too

    IBD
  26. Salix Dives On Miss, Probe

    IBD
  27. Indexes Higher; El Pollo Loco Reports In Line

    IBD
  28. Stocks Cling To Modest Gains; Advance Auto Rebounds

    IBD
  29. Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars

    IBD
  30. Earnings Scheduled For November 6, 2014

    Benzinga
  31. 3 IBD 50 Tech, Drug Stocks With Earnings Thursday

    IBD
  32. Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

    IBD
  33. Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

    IBD
  34. Stocks Hold Near Session Highs; Drugmakers Shine Again

    IBD
  35. Making Money With Charles Payne: 10/17/14

    FoxBusiness
  36. Will Activis Win Competition For Allergan's Affection?

    Benzinga
  37. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD
  38. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD
  39. Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble

    IBD
  40. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD
  41. Patents, Taxes Lift Drug M&A

    IBD
  42. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD
  43. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD
  44. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD
  45. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD
  46. Salix Pharmaceuticals

    IBD
  47. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD
  48. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  49. Stocks Further Deteriorate; Salix Breaks Support

    IBD
  50. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD
  51. Salix Bails On Tax Inversion

    IBD
  52. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD
  53. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD
  54. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD
  55. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  56. SALIX PHARMACEUTICALS

    IBD
  57. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD
  58. Stifel Raises Price Target On Salix Pharmaceuticals, Ltd. On ...

    Benzinga
  59. Morning Market Losers

    Benzinga
  60. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD
  61. Stocks Fade More In Late Trade; GoPro Hangs Tough

    IBD
  62. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD
  63. Jackson Square Partners Joins Investors Opposing Allergan Bid ...

    Benzinga
  64. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD
  65. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD
  66. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD
  67. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD
  68. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga
  69. Pharma Buyout Bids Beat On

    IBD
  70. Facebook, Three Other Leaders In Striking Distance

    IBD
  71. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD
  72. #PreMarket Primer: Wednesday, September 24: US Economy Looking ...

    Benzinga
  73. Ackman forewarns Allergan

    IBD
  74. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga
  75. Stocks Finish Lower Among Takeover Rumors

    IBD
  76. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga
  77. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD
  78. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares ...

    Benzinga
  79. Stocks Fall Modestly; New Issue Alibaba Extends Losses

    IBD
  80. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD
  81. Markets Mixed; Carnival Profit Tops Street View

    Benzinga
  82. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD
  83. Benzinga's Volume Movers

    Benzinga
  84. Stocks Hitting 52-Week Highs

    Benzinga
  85. Morning Market Movers

    Benzinga
  86. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD
  87. Benzinga's Top #PreMarket Gainers

    Benzinga
  88. #PreMarket Primer: Tuesday, September 23: First Airstrikes In ...

    Benzinga
  89. US Stock Futures Fall Ahead Of Economic Data

    Benzinga
  90. Stocks To Watch For September 23, 2014

    Benzinga
  91. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga
  92. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga
  93. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD
  94. Salix Secures Additional Intellectual Property Relating To Rifaximin

    Benzinga
  95. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD
  96. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD
  97. UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate ...

    Benzinga
  98. Nasdaq Sinks As Tesla, Other Highfliers Get Hit

    IBD
  99. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD
  100. Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, ...

    Benzinga
Trading Center